Enanta Pharmaceuticals
ENTA
#8253
Rank
โ‚น32.04 B
Marketcap
โ‚น1,100
Share price
-5.17%
Change (1 day)
19.10%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: โ‚น32.04 Billion

As of October 2026 Enanta Pharmaceuticals has a market cap of โ‚น32.04 Billion. This makes Enanta Pharmaceuticals the world's 8253th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น32.04 B-26.61%
2025โ‚น43.65 B299.53%
2024โ‚น10.92 B-33.76%
2023โ‚น16.49 B-79.39%
2022โ‚น80.06 B-29.85%
2021โ‚น114.13 B84.61%
2020โ‚น61.82 B-29.16%
2019โ‚น87.27 B-9.33%
2018โ‚น96.25 B34.32%
2017โ‚น71.66 B65.33%
2016โ‚น43.34 B5.1%
2015โ‚น41.24 B-31.25%
2014โ‚น59.98 B98.11%
2013โ‚น30.27 B

End of Day market cap according to different sources

On Oct 28th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

โ‚น32.04 Billion
by Nasdaq info icon info icon
โ‚น32.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น62.148 T 193,859.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น28.077 T 87,527.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น48.137 T 150,131.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น12.779 T 39,784.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น33.118 T 103,259.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.785 T 36,679.97%๐Ÿ‡บ๐Ÿ‡ธ USA